Accurate Preoperative Evaluation of the Location of Esophagogastric Junction Adenocarcinoma Using Positron Emission Tomography-Computed Tomography.
暂无分享,去创建一个
H. Eguchi | Y. Doki | M. Tatsumi | Kazuyoshi Yamamoto | Tsuyoshi Takahashi | K. Nakajima | Y. Kurokawa | T. Makino | Takuro Saito | K. Yamashita | Koji Tanaka | Noriko Wada
[1] Y. Doki,et al. Surgical Treatment of Gastroesophageal Junction Cancer , 2018, Journal of gastric cancer.
[2] Y. Seto,et al. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma , 2017, Gastric Cancer.
[3] Y. Doki,et al. Impact of number of [18F]fluorodeoxyglucose‐PET‐positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer , 2015, The British journal of surgery.
[4] T. Yoshikawa,et al. Ten‐year follow‐up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia , 2015, The British journal of surgery.
[5] W. Schreurs,et al. PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[6] E. Hindié,et al. Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[7] J. Hatazawa,et al. The Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography Positive Lymph Nodes on Postoperative Recurrence and Survival in Resectable Thoracic Esophageal Squamous Cell Carcinoma , 2012, Annals of Surgical Oncology.
[8] H. Shimada,et al. Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature , 2011, Gastric Cancer.
[9] B. Krause,et al. New trends for staging and therapy for localized gastroesophageal cancer: the role of PET. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] Z. Keidar,et al. Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis , 2010, Journal of Nuclear Medicine.
[11] Michael A. Blake,et al. Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements. , 2009, Academic radiology.
[12] N. Holalkere,et al. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] A. Fischman,et al. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. , 2008, The Annals of thoracic surgery.
[14] Soo Young Kim,et al. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. , 2007, European journal of cancer.
[15] J. Siewert,et al. The importance of PET in the diagnosis and response evaluation of esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[16] David Binns,et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] K. Kang,et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[18] Y. Doki,et al. Mucin phenotypic expression and background mucosa of esophagogastric junctional adenocarcinoma , 2004, Gastric Cancer.
[19] T. Sugino,et al. Expression of glucose transporter‐1 in human gastric carcinoma , 2001, Cancer.
[20] H. Stein,et al. Classification of adenocarcinoma of the oesophagogastric junction , 1998, The British journal of surgery.
[21] J. Wong,et al. Shrinkage of the Esophagus after Resection for Carcinoma , 1986, Annals of surgery.
[22] PhD Facs Hideo Baba MD,et al. Outcomes of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Esophagectomy in Patients with Resectable Node-Positive Esophageal Cancer , 2014, Annals of Surgical Oncology.
[23] Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.
[24] R L Wahl,et al. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.